Prosight Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-176,900
Closed -$4.86M – 41
2024
Q4
$4.86M Buy
+176,900
New +$4.93M 1.34% 22
2024
Q1
– Sell
-120,000
Closed -$4.88M – 46
2023
Q4
$4.88M Buy
+120,000
New +$4.42M 1.96% 15
2023
Q2
– Sell
-40,000
Closed -$1.55M – 41
2023
Q1
$1.55M Hold
40,000
– – 0.73% 30
2022
Q4
$1.78M Buy
+40,000
New +$1.68M 0.97% 26
2022
Q2
– Sell
-195,000
Closed -$12.1M – 29
2022
Q1
$12.1M Sell
195,000
-5,300
-3% -$324K 7.81% 4
2021
Q4
$11M Buy
200,300
+100,300
+100% +$5.23M 6.61% 4
2021
Q3
$5.26M Buy
+100,000
New +$5.94M 2.89% 12

Other funds holding LKFT

Prosight Management's LKFT Position: Q3 2026 in Review

Prosight Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 2.2% in Q3 2026, selling an estimated $1.29M and leaving 1,998,400 shares worth $59.3M. The position accounts for 11.49% of the portfolio, ranked #1.

Prosight Management first reported a position in LKFT in Q4 2018 and has held it in 24 quarters since. The position peaked at $61.3M in Q2 2026. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Prosight Management held 1,998,400 shares of Lakefront Biotherapeutics American Depositary Shares worth $59.3M as of Q3 2026.
  • Prosight Management sold 44,944 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $1.29M.
  • Lakefront Biotherapeutics American Depositary Shares made up 11.49% of Prosight Management's portfolio in Q3 2026, its #1 holding.
  • Prosight Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2018 and has held it in 24 quarters since.
  • Prosight Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $61.3M in Q2 2026.
  • 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.